Spatial and temporal analysis of invasive pneumococcal disease due to erythromycinresistant serotypes

被引:0
作者
Chavez, Abelardo Claudio Fernandez [1 ]
Comas, Luis Garcia [2 ]
Barroso, Diana Gomez [2 ,3 ]
Prieto, Rebeca Ramis [2 ,3 ]
Fresnena, Nieves Lopez [4 ]
Valdes, Cornelia Bishofberguer [1 ]
Andres, Jesus Maria Aranaz [1 ]
机构
[1] Hosp Univ Ramon y Cajal IRYCIS, Med Prevent, Madrid, Spain
[2] Consejeria San Comun Madrid, Serv Epidemiol, Madrid, Spain
[3] Ctr Nacl Epidemiol, Madrid, Spain
[4] Hosp Gen Univ Gregorio Maranon, Med Prevent, Madrid, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2023年 / 41卷 / 02期
关键词
Antibiotic resistance; Invasive pneumococcal disease; Use of antibiotics; RESISTANT STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; UNITED-STATES; SUSCEPTIBILITY; VACCINATION; PREVENTION; PREVALENCE;
D O I
10.1016/j.eimc.2021.06.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To study the spatio-temporal distribution of cases of invasive pneumococcal disease (IPD) due to serotypes resistant to erythromycin and its relationship with community consumption of macrolides and childhood vaccination coverage.Methods: We selected IPD cases in adults over 59 years old, residents in the Community of Madrid (MC), notified in the period 2007-2016. The variables studied were obtained from the Vaccination Information Systems and the Pharmaceutical Service. The cut-off point (minimum inhibitory erythromycin concen-tration > 0.5 mg/L) of the EUCAST classification was used to define erythromycin resistant serotypes. We used JointPoint to estimate the incidence trends by erythromycin resistant serotypes included in the 13 -valent vaccine (STPCV13) and not included in it (STnoPCV13). The association of these incidences with the community consumption of macrolides and vaccination coverage was made using Poisson models. Statistical scanning was used for the detection of temporal-spaces clusters of cases.Results: 1936 cases were identified, of which 427 erythromycin resistant serotypes were identified. The incidence of all cases due to resistant serotypes was decreasing (AAPC:-5,40%). During the period studied, the incidence of cases due to erythromycin resistant STPCV13 was decreasing with an annual percentage change (APC):-13.8 and was inversely associated with childhood vaccination coverage (IRR 0.641), while that of cases due to erythromycin resistant STnoPCV13 was ascending (APC): 4.5; and was not associated with coverage. 1 cluster was detected by STnoPCV13 and none by STPCV13 after the date of inclusion of the 13-valent in the childhood vaccination calendar.Conclusions: The decrease in IPD due to resistant STPCV13 was associated with an increase in childhood vaccination coverage. The presence of clusters due to STnoPCV13 after the date of inclusion of the 13 -valent vaccine in the childhood vaccination calendar indicates serotypes replacement. The increase in cases of resistant STnoPCV13 could be related to the replacement of vaccine serotypes in nasopharyngeal colonization, facilitated by the consumption of macrolides still at high levels in MC. (c) 2021 Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 50 条
  • [1] Temporal Trends in Invasive Pneumococcal Disease and Pneumococcal Serotypes over 7 Decades
    Harboe, Zitta B.
    Benfield, Thomas L.
    Valentiner-Branth, Palle
    Hjuler, Thomas
    Lambertsen, Lotte
    Kaltoft, Margit
    Krogfelt, Karen
    Slotved, Hans Christian
    Christensen, Jens Jorgen
    Konradsen, Helle B.
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (03) : 329 - 337
  • [2] Association of Serotypes of Streptococcus pneumoniae with Age in Invasive Pneumococcal Disease
    Imoehl, Matthias
    Reinert, Ralf Rene
    Ocklenburg, Christina
    van der Linden, Mark
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (04) : 1291 - 1296
  • [3] Evolutionary trend of invasive pneumococcal disease according to serotypes
    Medina, Maria Jose Galvez
    Pinedo, Angela Ramos
    Canovas, Jose Francisco Valverde
    Perez, Elia
    Solano, Javier
    Izquierdo, Mercedes
    Echave, Nurua
    Hernandez, Marta Inmaculada
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [4] Invasive pneumococcal disease in relation to vaccine type serotypes
    Wantuch, Paeton L.
    Avci, Fikri Y.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 874 - 875
  • [5] Understanding the link between pneumococcal serotypes and invasive disease
    Soley, Carolina
    Arguedas, Adriano
    VACCINE, 2009, 27 : C19 - C21
  • [6] Non-vaccine Pneumococcal Serotypes Among Children with Invasive Pneumococcal Disease
    John, James
    Varghese, Rosemol
    Lionell, Jones
    Neeravi, Ayyanraj
    Veeraraghavan, Balaji
    INDIAN PEDIATRICS, 2018, 55 (10) : 874 - 876
  • [7] Non-vaccine Pneumococcal Serotypes Among Children with Invasive Pneumococcal Disease
    James John
    Rosemol Varghese
    Jones Lionell
    Ayyanraj Neeravi
    Balaji Veeraraghavan
    Indian Pediatrics, 2018, 55 : 874 - 876
  • [8] Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010
    Lamb, Karen E.
    Flasche, Stefan
    Diggle, Mathew
    Inverarity, Donald
    Greenhalgh, David
    Jefferies, Johanna M.
    Smith, Andrew
    Edwards, Giles F. S.
    Denham, Barbara
    McMenamin, Jim
    McDonald, Eisin
    Mitchell, Tim J.
    Clarke, Stuart C.
    Robertson, Chris
    VACCINE, 2014, 32 (34) : 4356 - 4363
  • [9] Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes
    Molander, Viktor
    Elisson, Camilla
    Balaji, Veeraraghavan
    Backhaus, Erik
    John, James
    Vargheese, Rosemol
    Jayaraman, Ranjith
    Andersson, Rune
    BMC INFECTIOUS DISEASES, 2013, 13
  • [10] Routine Pneumococcal Vaccination of Children Provokes New Patterns of Serotypes Causing Invasive Pneumococcal Disease in Adults and Children
    Norton, Nancy B.
    Stanek, Ronald J.
    Mufson, Maurice A.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 345 (02) : 112 - 120